Estimation of cutoff values of cotinine in urine and saliva for pregnant women in Poland

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Stragierowicz, Joanna ^a   Mikołajewska, Karolina ^a   Zawadzka Stolarz, Marta ^a   Polańska, Kinga ^a   Ligocka, Danuta ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; CREATININE; DIAGNOSTIC AGENT;

ADULT; CORRELATIONAL STUDY; CREATININE URINE LEVEL; DRUG SALIVA LEVEL; DRUG URINE LEVEL; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; POLAND; PREGNANT WOMAN; REFERENCE VALUE; REVIEW; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; SMOKING; TANDEM MASS SPECTROMETRY; THIRD TRIMESTER PREGNANCY; ARTICLE; CHEMISTRY; PREGNANCY; REGRESSION ANALYSIS; SALIVA; URINE;

ADULT; CHROMATOGRAPHY, LIQUID; COTININE; FEMALE; HUMANS; POLAND; PREGNANCY; REGRESSION ANALYSIS; SALIVA; SMOKING; TANDEM MASS SPECTROMETRY;

EID: 84887469660     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/386784     Document Type: Review

References (50)

1. Benowitz N. L., Biomarkers of environmental tobacco smoke exposure. Environmental Health Perspectives 1999 107 2 349 355 2-s2.0-0033028068
2. SRNT Subcommittee on Biochemical Verification, Biochemical verification of tobacco use and cessation. Nicotine and Tobacco Research 2002 4 2 149 159 2-s2.0-18444361814 10.1080/14622200210123581
3. Benowitz N. L., Jacob P. III, Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clinical Pharmacology and Therapeutics 1994 56 5 483 493 2-s2.0-0027987497
4. Benowitz N. L., Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiologic Reviews 1996 18 2 188 204 2-s2.0-0030499698
5. Kozlowski L. T., Mehta N. Y., Sweeney C. T., Schwartz S. S., Vogler G. P., Jarvis M. J., West R. J., Filter ventilation and nicotine content of tobacco in cigarettes from Canada, the United Kingdom, and the United States. Tobacco Control 1998 7 4 369 375 2-s2.0-0032241624
6. Benowitz N. L., Jacob P. III, Daily intake of nicotine during cigarette smoking. Clinical Pharmacology and Therapeutics 1984 35 4 499 504 2-s2.0-0021270837
7. Global Adult Tobacco Survey (GATS), Fact Sheet Poland: 2009-2010. http://nccd.cdc.gov/GTSSData/Ancillary/DataReports.aspx?CAID=1
8. Wojtyła A., Goździewska M., Paprzycki P., Biliński P., Tobacco-related foetal origin of adult diseases hypothesis-population studies in Poland. Annals of Agricultural and Environmental Medicine 2012 19 1 117 128 2-s2.0-84859348313
9. Haufroid V., Lison D., Urinary cotinine as a tobacco-smoke exposure index. A minireview. International Archives of Occupational and Environmental Health 1998 71 3 162 168 2-s2.0-0031979685 10.1007/s004200050266
10. IARC, IARC Monographs on Evaluation of Carcinogenic Risks to Humans, Volume 83: Tobacco Smoke and Involuntary Smoking 2002 Lyon, France WHO International Agency for Research on Cancer
11. Benowitz N. L., Dempsey D. A., Pharmacotherapy for smoking cessation during pregnancy. Nicotine and Tobacco Research 2004 6 supplement 2 S189 S202 2-s2.0-2542440683 10.1080/14622200410001669169
12. Castles A., Adams E. K., Melvin C. L., Kelsch C., Boulton M. L., Effects of smoking during pregnancy: five meta-analyses. The American Journal of Preventive Medicine 1999 16 3 208 215 2-s2.0-0033121104 10.1016/S0749-3797(98) 00089-0
13. Polańska K., Hanke W., Sobala W., Ligocka D., Impact of prenatal environmental tobacco smoke exposure on birth parameters. Przegld Lekarski 2010 67 10 835 837 2-s2.0-80051749382
14. Maritz G. S., Harding R., Life-long programming implications of exposure to tobacco smoking and nicotine before and soon after birth: evidence for altered lung development. International Journal of Environmental Research and Public Health 2011 8 3 875 898 2-s2.0-79953277323 10.3390/ijerph8030875
15. Nakajima M., Yokoi T., Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation. Drug Metabolism and Pharmacokinetics 2005 20 4 227 235 2-s2.0-31344445949
16. Dempsey D., Jacob P. III, Benowitz N. L., Accelerated metabolism of nicotine and cotinine in pregnant smokers. Journal of Pharmacology and Experimental Therapeutics 2002 301 2 594 598 2-s2.0-0036231675 10.1124/jpet.301.2.594
17. Higashi E., Fukami T., Itoh M., Kyo S., Inoue M., Yokoi T., Nakajima M., Human CYP2A6 is induced by estrogen via estrogen receptor. Drug Metabolism and Disposition 2007 35 10 1935 1941 2-s2.0-34748881453 10.1124/dmd.107.016568
18. Messina E. S., Tyndale R. F., Sellers E. M., A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. Journal of Pharmacology and Experimental Therapeutics 1997 282 3 1608 1614 2-s2.0-0030885491
19. Rebagliato M., Bolumar F., Florey C. D. V., Jarvis M. J., Perez-Hoyos S., Hernandez-Aguado I., Avino M. J., Variations in cotinine levels in smokers during and after pregnancy. The American Journal of Obstetrics and Gynecology 1998 178 3 568 571 2-s2.0-0031968588 10.1016/S0002-9378(98)70440-5
20. Benowitz N. L., Bernert J. T., Caraballo R. S., Holiday D. B., Wang J., Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. The American Journal of Epidemiology 2009 169 2 236 248 2-s2.0-58449088706 10.1093/aje/kwn301
21. Zielińska-Danch W., Wardas W., Sobczak A., Szołtysek- Bołdys I., Estimation of urinary cotinine cut-off points distinguishing non-smokers, passive and active smokers. Biomarkers 2007 12 5 484 496 2-s2.0-34548166042 10.1080/13547500701421341
22. Zielińska-Danch W., Goniewicz M. L., Szołtysek- Bołdys I., Czogała J., Koszowski B., Słodczyk E., Anczyk E., Sobczak A., Estimation of optimal levels of tobacco biomarkers to distinguish active and passive smokers using ROC analysis. Przegld Lekarski 2009 66 10 636 640 2-s2.0-77953934464
23. Goniewicz M. L., Eisner M. D., Lazcano-ponce E., Zielinska-danch W., Koszowski B., Sobczak A., Havel C., Jacob P., Benowitz N. L., Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking. Nicotine and Tobacco Research 2011 13 3 202 208 2-s2.0-79957880610 10.1093/ntr/ntq237
24. Polańska K., Hanke W., Gromadzińska J., Ligocka D., Gulczyńska E., Sobala W., Wsowicz W., Polish mother and child cohort study-defining the problem, the aim of the study and methodological assumptions. International Journal of Occupational Medicine and Environmental Health 2009 22 4 383 391 2-s2.0-77749237315 10.2478/v10001-009-0037-0
25. WHO, Biological Monitoring of Chemicals Exposure in the Workplace 1996 1 Geneva, Switzerland WHO
26. Perkins N. J., Schisterman E. F., The inconsistency of-optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. The American Journal of Epidemiology 2006 163 7 670 675 2-s2.0-33645311528 10.1093/aje/kwj063
27. Matsumoto A., Ino T., Ohta M., Otani T., Hanada S., Sakuraoka A., Matsumoto A., Ichiba M., Hara M., Enzyme-linked immunosorbent assay of nicotine metabolites. Environmental Health and Preventive Medicine 2010 15 4 211 216 2-s2.0-77956457259 10.1007/s12199-009-0129-2
28. Kardani F., Daneshfar A., Sahrai R., Determination of nicotine, anabasine, and cotinine in urine and saliva samples using single-drop microextraction. Journal of Chromatography B 2010 878 28 2857 2862 2-s2.0-77957300962 10.1016/j.jchromb.2010.08.041
29. Toraño J. S., van Kan H. J. M., Simultaneous determination of the tobacco smoke uptake parameters nicotine, cotinine and thiocyanate in urine, saliva and hair, using gas chromatography-mass spectrometry for characterisation of smoking status of recently exposed subjects. Analyst 2003 128 7 838 843 2-s2.0-0041845176 10.1039/b304051h
30. Kuhn J., Vollmer T., Martin C., Hendig D., Knabbe C., Fast and sample cleanup-free measurement of nicotine and cotinine by stable isotope dilution ultra-performance liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2012 67-68 137 143 10.1016/j.jpba.2012. 04.036
31. Jacob P. III, Yu L., Duan M., Ramos L., Yturralde O., Benowitz N. L., Determination of the nicotine metabolites cotinine and trans-3′- hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. Journal of Chromatography B 2011 879 3-4 267 276 2-s2.0-78751704916 10.1016/j.jchromb.2010.12.012
32. Song L., Davis W., Abrams S. M., Hemiup J., Kazim A. L., Cummings K. M., Mahoney M. C., Sensitive and rapid method for the determination of urinary cotinine in non-smokers: an application for studies assessing exposures to second hand smoke (SHS). Analytica Chimica Acta 2005 545 2 200 208 2-s2.0-21244458432 10.1016/j.aca.2005.04.051
33. Gabr R. Q., Elsherbiny M. E., Somayaji V., Pollak P. T., Brocks D. R., A liquid chromatography-mass spectrometry method for nicotine and cotinine; utility in screening tobacco exposure in patients taking amiodarone. Biomedical Chromatography 2011 25 10 1124 1131 2-s2.0-80052551707 10.1002/bmc.1581
34. Shin H. S., Kim J. G., Shin Y. J., Jee S. H., Sensitive and simple method for the determination of nicotine and cotinine in human urine, plasma and saliva by gas chromatography-mass spectrometry. Journal of Chromatography B 2002 769 1 177 183 2-s2.0-0037170809 10.1016/S1570-0232(02)00007-7
35. Apinan R., Choemung A., Na-Bangchang K., A sensitive HPLC-ESI-MS-MS method for the determination of cotininein urine. Journal of Chromatographic Science 2010 48 6 460 465 2-s2.0-77955508580
36. Jessome L. L., Volmer D. A., Ion suppression: a major concern in mass spectrometry. LC-GC North America 2006 24 5 498 510 2-s2.0-33745106913
37. Klebanoff M. A., Levine R. J., Clemens J. D., Dersimonian R., Wilkins D. G., Serum cotinine concentration and self-reported smoking during pregnancy. The American Journal of Epidemiology 1998 148 3 259 262 2-s2.0-0032147036
38. Jarvis M. J., Primatesta P., Erens B., Feyerabend C., Bryant A., Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates. Nicotine and Tobacco Research 2003 5 3 349 355 2-s2.0-0037804776 10.1080/14622200307204
39. Jarvis M. J., Tunstall-Pedoe H., Feyerabend C., Vesey C., Saloojee Y., Comparison of tests used to distinguish smokers from nonsmokers. The American Journal of Public Health 1987 77 11 1435 1438 2-s2.0-0023513783
40. Jarvis M. J., Fidler J., Mindell J., Feyerabend C., West R., Assessing smoking status in children, adolescents and adults: cotinine cut-points revisited. Addiction 2008 103 9 1553 1561 2-s2.0-49249098981 10.1111/j.1360-0443.2008.02297.x
41. Sasaki S., Braimoh T. S., Yila T. A., Yoshioka E., Kishi R., Self-reported tobacco smoke exposure and plasma cotinine levels during pregnancy-a validation study in Northern Japan. Science of the Total Environment 2011 412-413 114 118 2-s2.0-84855832825 10.1016/j.scitotenv.2011.10.019
42. Hegaard H. K., Kjaergaard H., Møller L. F., Wachmann H., Ottesen B., Determination of a saliva cotinine cut-off to distinguish pregnant smokers from pregnant non-smokers. Acta Obstetricia et Gynecologica Scandinavica 2007 86 4 401 406 2-s2.0-34248575827 10.1080/00016340601147517
43. Owen L., McNeill A., Saliva cotinine as indicator of cigarette smoking in pregnant women. Addiction 2001 96 7 1001 1006 2-s2.0-0034913680 10.1046/j.1360-0443.2001.96710019.x
44. Boyd N. R., Windsor R. A., Perkins L. L., Lowe J. B., Quality of measurement of smoking status by self-report and saliva cotinine among pregnant women. Maternal and Child Health Journal 1998 2 2 77 83 2-s2.0-0032081729
45. Jhun H. J., Seo H. G., Lee D. H., Sung M. W., Kang Y. D., Syn H. C., Jun J. K., Self-reported smoking and urinary cotinine levels among pregnant women in Korea and factors associated with smoking during pregnancy. Journal of Korean Medical Science 2010 25 5 752 757 2-s2.0-77955293214 10.3346/jkms.2010.25.5.752
46. Bramer S. L., Kallungal B. A., Clinical considerations in study designs that use cotinine as a biomarker. Biomarkers 2003 8 4 187 203 2-s2.0-0141615686 10.1080/13547500310012545
47. McGanity W. J., Dawson E. B., Fogelman A., Shils M. E., Olson J. A., Shike M., Nutrition in pregnancy and lactation. Modern Nutrition in Health and Disease 1994 8th London, UK Lea and Febiger 705 726
48. Jatlow P., McKee S., O'Malley S. S., Correction of urine cotinine concentrations for creatinine excretion: is it useful? Clinical Chemistry 2003 49 11 1932 1934 2-s2.0-0242331101 10.1373/clinchem.2003.023374
49. Petersen G. O., Leite C. E., Chatkin J. M., Thiesen F. V., Cotinine as a biomarker of tobacco exposure: development of a HPLC method and comparison of matrices. Journal of Separation Science 2010 33 4-5 516 521 2-s2.0-77749336342 10.1002/jssc.200900575
50. Barr D. B., Wilder L. C., Caudill S. P., Gonzalez A. J., Needham L. L., Pirkle J. L., Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environmental Health Perspectives 2005 113 2 192 200 2-s2.0-14744271278 10.1289/ehp.7337